New Drug Design Avenues Targeting Alzheimer's Disease by Pharmacoinformatics-Aided Tools

• Main Authors: Lily Arrué (Author), Alexandra Cigna-Méndez (Author), Tábata Barbosa (Author), Paola Borrego-Muñoz (Author), Silvia Struve-Villalobos (Author), Victoria Oviedo (Author), Claudia Martínez-García (Author), Alexis Sepúlveda-Lara (Author), Natalia Millán (Author), José C. E. Márquez Montesinos (Author), Juana Muñoz (Author), Paula A. Santana (Author), Carlos Peña-Varas (Author), George E. Barreto (Author), Janneth González (Author), David Ramírez (Author)
• Format: Book
• Published: MDPI AG, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time due to their multifactorial character. Among these pathologies, Alzheimer's disease (AD) is of special relevance, and despite the existence of approved drugs for its treatment, there is still no efficient...